Top

BY Jill Delsigne

Cancer survivors are more likely to die from heart disease than cancer; therefore, patients must be closely monitored for heart problems during and after cancer treatment. Such surveillance can be done continuously with new implantable cardiac monitoring devices.

The need for cardiac monitoring is evidenced by estimates of heart failure in cancer patients during chemotherapy; such estimates range from 3% to 50% depending on the...